COMBINATION THERAPY COMPRISING A RAF INHIBITOR AND TRAMETINIB

    公开(公告)号:EP4272740A1

    公开(公告)日:2023-11-08

    申请号:EP23166366.7

    申请日:2018-04-30

    申请人: Novartis AG

    发明人: COOKE, Vesselina

    摘要: The present invention relates to a pharmaceutical combination comprising (a) a Raf inhibitor as defined herein, or a pharmaceutically acceptable salt thereof and (b) a MEK inhibitor, particularly trametinib, particularly for use in the treatment of a proliferative disease. This invention also relates to uses of such combination for preparation of a medicament for the treatment of a proliferative disease; methods of treating a proliferative disease in a subject in need thereof comprising administering to said subject a jointly therapeutically effective amount of said combination; use of such combination for the treatment of proliferative disease; pharmaceutical compositions comprising such combination and commercial packages thereto.